tiprankstipranks
Fennec Pharmaceuticals (TSE:FRX)
TSX:FRX
FRX
Fennec Pharmaceuticals
RESEARCH TOOLSreports
Want to see TSE:FRX full AI Analyst Report?

Fennec Pharmaceuticals (FRX) Revenue

35 Followers
StatisticsMarket CapRevenue

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had a revenue of 13.99M in the quarter ending Dec 31, 2025, with 12.25%. This bring the company's revenue in the last twelve months to 44.85M, Decreased 15.63%. In the fiscal year ending Dec 31, 2025, Fennec Pharmaceuticals had annual revenue of 45.42M with -4.45% growth.
Revenue (ttm)
44.85M
Revenue Growth
-3.80%
P/S Ratio
7.45
Revenue/Employee
C$1,419,484
Employees
32
Market Cap
C$338.20M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
45.42M-2.11M-4.45%
Dec 31, 2024
47.54M26.29M+123.69%
Dec 31, 2023
21.25M19.72M+1,284.50%
Dec 31, 2022
1.53M―+∞%
Dec 31, 2021
―-170.00K-100.00%
Dec 31, 2020
170.00K―+∞%
Dec 31, 2019
―――
Dec 31, 2018
―――
Dec 31, 2017
―――